# Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia

> **NCT00950196** · PHASE4 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Ataxia
- Chorea
- Dystonia
- Parkinsonism
- Fatigue

## Interventions

- **DRUG:** amantadine sulphate

## Key facts

- **NCT ID:** NCT00950196
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950196, "Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00950196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*